Virtus ETF Advisers’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-36,084
| Closed | -$324K | – | 307 |
|
|
2024
Q4 | $324K | Sell |
36,084
-25,477
| -41% | -$229K | 0.13% | 235 |
|
|
2024
Q3 | $451K | Hold |
61,561
| – | – | 0.21% | 188 |
|
|
2024
Q2 | $352K | Buy |
61,561
+19,366
| +46% | +$111K | 0.17% | 196 |
|
|
2024
Q1 | $211K | Buy |
42,195
+6,071
| +17% | +$30.4K | 0.11% | 244 |
|
|
2023
Q4 | $325K | Buy |
36,124
+5,267
| +17% | +$47.4K | 0.21% | 212 |
|
|
2023
Q3 | $240K | Sell |
30,857
-3,993
| -11% | -$31K | 0.15% | 228 |
|
|
2023
Q2 | $337K | Sell |
34,850
-31,098
| -47% | -$301K | 0.2% | 172 |
|
|
2023
Q1 | $723K | Buy |
65,948
+1,162
| +2% | +$12.7K | 0.4% | 122 |
|
|
2022
Q4 | $280K | Buy |
64,786
+39,866
| +160% | +$172K | 0.15% | 295 |
|
|
2022
Q3 | $187K | Buy |
24,920
+364
| +1% | +$2.73K | 0.07% | 325 |
|
|
2022
Q2 | $247K | Buy |
24,556
+3,903
| +19% | +$39.3K | 0.09% | 300 |
|
|
2022
Q1 | $256K | Hold |
20,653
| – | – | 0.11% | 184 |
|
|
2021
Q4 | $472K | Buy |
+20,653
| New | +$472K | 0.18% | 120 |
|